NEW YORK--Manhattan Scientifics Inc., today announced that the company is involved in discussions to license its nano-metals technology and related intellectual property to a medical industry metals manufacturer.
Manhattan Scientifics has to date received $500,000 good faith and machinery payments from the sale of equipment to the manufacturer.
Discussions with this manufacturer have been on-going for an extended period. The closing of such agreement is subject to continued due diligence, drafting a definitive agreement and approval of our Board of Directors. There can be no guarantee that we will satisfactorily conclude a commercial arrangement with this manufacturer.
Manhattan Scientifics Inc. (www.mhtx.com) is located in New Mexico, New York and Montreal. It is focused on technology transfer and commercialization of transformative technologies.
This press release contains forward-looking statements, which are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected in such forward-looking statements. Management at Manhattan Scientifics believes that purchase of its shares should be considered to be at the high end of the risk spectrum. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly update or revise any forward-looking statements.